Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-02-12

Clinical Trial Update: Phase 2 Study of DS-8500a in Patients With Type 2 Diabetes [Phase 2]

View source ↗

Summary

A Phase 2 study of DS-8500a for Type 2 diabetes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DS-8500a

Snippet

Sponsor: Daiichi Sankyo Co., Ltd. | Conditions: Type 2 Diabetes Mellitus | Phase 2 | Status: COMPLETED